News Results
There are 794,381 News Results
May 8, 2019
BROOKLYN, N.Y., May 8, 2019 /PRNewswire/ -- Etsy, Inc. (NASDAQ: ETSY), the global two-sided marketplace for unique and creative goods, today announced financial results for its first quarter ended March...
May 9, 2019
ST. LOUIS, May 9, 2019 /PRNewswire/ -- Ameren Corporation (NYSE: AEE) today announced first quarter 2019 net income attributable to common shareholders of $191 million, or $0.78 per diluted share,...
May 10, 2019
NuStar Energy L.P. (NYSE: NS) today announced plans to sell its St. Eustatius Terminal, reported the company’s first quarter 2019 earnings results and reviewed NuStar’s growth and growth projects, in...
May 15, 2019
SOUTH SAN FRANCISCO, Calif., May 15, 2019 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) today reported financial results for the first quarter ended March 31, 2019 and provided an update...
May 24, 2019
EAST HANOVER, N.J., May 24, 2019 /PRNewswire/ -- Novartis today announced the US Food and Drug Administration (FDA) has approved Piqray(®) (alpelisib, formerly BYL719) in combination with fulvestrant for the...
May 28, 2019
ROCKLAND, Mass., May 28, 2019 /PRNewswire/ -- EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, will present data from its multiple sclerosis (MS)...
Jun 15, 2019
CAMBRIDGE, Mass., June 15, 2019 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, today announced updated data...
Jul 31, 2019
Holly Energy Partners, L.P. (“HEP” or the “Partnership”) (NYSE:HEP) today reported financial results for the second quarter of 2019. Net income attributable to HEP for the second quarter was $45.7...
Aug 7, 2019
Foresight Energy LP (“Foresight” or the “Partnership”) (NYSE: FELP) today reported financial and operating results for the second quarter ended June 30, 2019. Foresight generated second quarter coal sales revenues...
Jul 6, 2019
BOULDER, Colo., July 6, 2019 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced the presentation of results from the Phase 3 BEACON CRC trial evaluating the combination of BRAFTOVI(®...
